• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number ASKU
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Fainting (1847); Ischemia (1942)
Event Date 09/04/2020
Event Type  Injury  
Manufacturer Narrative
The reporter's product was requested for investigation.The product has not been received at this time.If the product is returned in the future, a follow up report will be submitted.Routine retention testing is performed.Retention testing data is reviewed and appropriate actions are taken as needed.Test strip retention samples passed the internal inspection.Reporter occupation - the occupation is lay user/patient.This event occurred in (b)(6).
 
Event Description
The initial reporter stated she received a blood clot in her brain due to use of coaguchek xs meter serial number (b)(4).On the day of the event, a sample from the patient was tested using the meter, resulting with a value of 3.2 inr.At an unknown time on the same day, the patient was tested in the laboratory using an unknown method, resulting with a value of 2.69 inr.The reporter stated that coumadin medication adjustments were made based on incorrect results obtained from the meter.This led to the patient having a blood clot in the brain on (b)(6) 2020.The blood clot caused the patient to lose consciousness and speech.The patient has regained consciousness and is doing well again.The patient also regained her ability to speak.The patient's therapeutic target is a minimum of 3.0 inr.
 
Manufacturer Narrative
The reporter's meter was provided for investigation where it was tested using retention controls.The meter appeared undamaged and clean on the outside.Results (qc range = 2.7-3.3 inr): qc 1 = 3.1 inr, qc 2 = 3.1 inr, qc 3 = 3.1 inr, all inr values were within the specified target ranges, confirming the functionality of the complained coaguchek meter.No error messages occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11226047
MDR Text Key228662554
Report Number1823260-2021-00252
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Type of Report Initial,Followup
Report Date 02/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/31/2020
Initial Date FDA Received01/25/2021
Supplement Dates Manufacturer Received12/31/2020
Supplement Dates FDA Received02/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ANORO; AZARGA; BELOC; COUMADIN; DESYREL; HYZAAR; KAPRIL; LASIX; MITRAL VALVE HEART; NORVASC; PAXIL; TEBOKAN; XALATAN; ANORO; AZARGA; BELOC; COUMADIN; DESYREL; HYZAAR; KAPRIL; LASIX; MITRAL VALVE HEART; NORVASC; PAXIL; TEBOKAN; XALATAN
Patient Outcome(s) Hospitalization;
Patient Age72 YR
Patient Weight65
-
-